Sarepta Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Sarepta Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q4 2024.
  • Sarepta Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending December 31, 2024 was $79.9M, a 41.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $79.9M -$56.9M -41.6% Dec 31, 2024 10-K 2025-02-28
Q3 2024 $83.6M -$53.4M -39% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $136M -$27.3M -16.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $176M +$14M +8.63% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $137M -$26.2M -16.1% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $137M -$156M -53.3% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $163M -$121M -42.6% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $162M -$116M -41.7% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $163M -$130M -44.4% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $293M +$102M +53.6% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $284M +$80.6M +39.6% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $279M +$67.1M +31.7% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $293M +$89.2M +43.8% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $191M -$11.1M -5.48% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $204M +$20.6M +11.2% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $212M +$24.8M +13.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $204M +$29.8M +17.2% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $202M +$32.7M +19.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $183M +$31.1M +20.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $187M +$53.5M +40.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $174M +$66.6M +62% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $169M +$90.5M +115% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $152M +$116M +329% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $133M +$121M +969% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $107M +$85.5M +392% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $78.7M +$67.7M +616% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $35.4M +$23.9M +206% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $12.5M +$5.12M +69.7% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $21.8M +$17.8M +450% Dec 31, 2017 10-Q 2018-10-31
Q3 2017 $11M +$2.94M +36.5% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $11.6M +$4.64M +66.8% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $7.35M -$799K -9.81% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $3.97M -$503K -11.3% Dec 31, 2016 10-Q 2017-11-01
Q3 2016 $8.05M +$381K +4.97% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $6.94M +$1.63M +30.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $8.15M +$2.87M +54.4% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $4.47M +$2.41M +117% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $7.67M +$1.94M +33.9% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $5.31M -$1.13M -17.5% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $5.28M +$5.25M Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $2.06M +$2.04M Dec 31, 2014 10-K 2016-02-25
Q3 2014 $5.73M +$5.7M Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $6.44M +$4.82M +296% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $25K* -$1.5M Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $25K* -$2.75M Dec 31, 2013 10-K 2015-02-26
Q3 2013 $25K* -$2.4M Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $1.63M +$1.39M +603% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $1.53M +$1.32M +640% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $2.78M +$2.62M +1690% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $2.43M +$2.29M +1645% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $231K +$108K +87.8% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $206K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $155K +$32K +26% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $139K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $123K Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $123K Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.